These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 790835)

  • 1. [Better characterization of antinuclear factors (proceedings)].
    Stojan B
    Z Rheumatol; 1976; 35 Suppl 4():suppl 427-32. PubMed ID: 790835
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities of differentiation of antinuclear antibodies].
    Müller W; Rosenthal M; Stojan B
    Z Gesamte Inn Med; 1975 Oct; 30(20):665-71. PubMed ID: 766433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
    Sheon RP; Kirsner AB
    Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance and diagnostic value of different types of antinuclear antibodies demonstrated by immunofluorescence on smears of trypanosomed mice blood].
    Monier JC; Thivolet J; Sepetjian M; Beyvin AJ; Pousset G
    Lyon Med; 1970 May; 223(20):1007-18. PubMed ID: 4913277
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
    Stojan B
    Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Wager O
    Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antinuclear factors. Demonstration and clinico-diagnostic significance].
    Maas D
    Med Klin; 1969 Jul; 64(29):1302-7. PubMed ID: 4184549
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
    Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-DNA determination using Crithidia luciliae. Specificity and clinical usefulness in systemic lupus erythematosus].
    Pena Sagredo JL; Orte Martinez FJ; Sanchez Andrada S; Sampedro Alvarez J; Novo Fernandez MJ; Rodriguez Valverde V
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):345-50. PubMed ID: 7048503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies against native (double-strand) deoxyribonucleic acid and complement fixing antibodies in generalized lupus erythematosus with affected kidneys].
    Dostál C; Hána I; Bardfeld R; Stejskal J; Matl I; Zvárová J
    Vnitr Lek; 1984 May; 30(5):417-25. PubMed ID: 6331681
    [No Abstract]   [Full Text] [Related]  

  • 12. Antinucleolar antibodies. Their frequency and diagnostic association.
    Ritchie RF
    N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic lupus erythematosus: antinuclear serology and cell-mediated immunity in the light of clinico-hematologic diagnostic criteria. Preliminary communication.
    Bitter T
    Schweiz Med Wochenschr; 1971 Feb; 101(6):181-6. PubMed ID: 4104947
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmunity and laboratory testing for systemic lupus erythematosus (SLE) and allied diseases.
    Deodhar SD
    Lab Res Methods Biol Med; 1983; 8():89-100. PubMed ID: 6358749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus].
    Kostadinova DA; Razboĭnikov S
    Vutr Boles; 1976; 15(2):18-26. PubMed ID: 59467
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current immunological diagnosis of collagenoses. I. Systemic lupus erythematosus and systemic scleroderma].
    Jarzabek-Chorzelska M; Kołacińska-Strasz Z; Błaszczyk M; Chorzelski T; Jabłońska S
    Przegl Dermatol; 1987; 74(6):421-30. PubMed ID: 3330246
    [No Abstract]   [Full Text] [Related]  

  • 19. The relative value of antibody assays in the differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with special emphasis to ultramicro ELISA for anti-ds DNA.
    Wollina U
    Dermatol Monatsschr; 1984; 170(10):645-7. PubMed ID: 6391968
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
    Traycoff RB; Rogers WW; Gregory SA
    J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.